Publications by authors named "E T THIEME"

Diffuse large B-cell lymphoma (DLBCL) exhibits significant genetic heterogeneity which contributes to drug resistance, necessitating development of novel therapeutic approaches. Pharmacological inhibitors of cyclin-dependent kinases (CDK) demonstrated pre-clinical activity in DLBCL, however many stalled in clinical development. Here we show that AZD4573, a selective inhibitor of CDK9, restricted growth of DLBCL cells.

View Article and Find Full Text PDF

B-cell activating factor receptor (BAFF-R) is a mature B-cell survival receptor, which is highly expressed in a wide variety of B-cell malignancies but with minimal expression in immature B cells. These properties make BAFF-R an attractive target for therapy of B-cell lymphomas. We generated a novel humanized anti BAFF-R monoclonal antibody (mAb) with high specificity and potent in vitro and in vivo activity against B-cell lymphomas and leukemias.

View Article and Find Full Text PDF
Article Synopsis
  • * CG-806 (luxeptinib) is a promising dual BTK/SYK inhibitor that has shown effectiveness in preclinical trials, killing MCL cells and overcoming resistance seen with ibrutinib by suppressing anti-apoptotic proteins.
  • * In studies, CG-806 improved survival rates in certain MCL models, revealing that understanding the Bcl-2 network and combining it with other treatments could enhance drug efficacy, making it a focus for future cancer therapy research. *
View Article and Find Full Text PDF

Three novel corynebacterial species were isolated from soil sampled at a paddock in Vilsendorf, North Rhine-Westphalia, Germany. The strains were coccoid or irregular rod-shaped, catalase-positive and pale white to yellow-orange in colour. By whole genome sequencing and comparison of the 16S rRNA genes as well as the whole genome structure, it was shown that all three strains represent novel species of the family , order , class .

View Article and Find Full Text PDF